0001209191-14-010161.txt : 20140213 0001209191-14-010161.hdr.sgml : 20140213 20140213123500 ACCESSION NUMBER: 0001209191-14-010161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140211 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYNCH DANIEL CENTRAL INDEX KEY: 0001177082 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 14604379 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-02-11 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001177082 LYNCH DANIEL C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 1 0 0 0 Common Stock (restricted) 2014-02-11 4 A 0 70879 A 161430 D The shares of restricted common stock vest over four years, with 6.25% of the shares vesting at the end of each successive three-month period after February 11, 2014. The shares of restricted Common Stock were issued in consideration of services rendered and to be rendered by Mr. Lynch. /s/ Daniel S. Lynch 2014-02-13